POPS RICHARD F

CIK 00011264906 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001126490

Recent Transactions

50 trades

Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2025-05-22+2,869→ 34,480 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-22−2,869→ 0 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2025-05-21+3,318→ 3,318 total
Award
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2025-02-19+293,921→ 293,921 total
Award
Alkermes plc.$ALKS
Ordinary Shares
2025-02-06+190,640→ 1,370,315 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2025-02-06$31.39/sh−79,925→ 1,290,390 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-22+2,869→ 2,869 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2024-05-17−4,199→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-17$141.84/sh−2,100→ 31,611 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-05-17+4,199→ 33,711 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-13$42.76/sh+23,200→ 52,712 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-03-13$42.76/sh−23,200→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-13$140.33/sh−23,200→ 29,512 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-11$140.00/sh−100→ 29,512 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-11$42.76/sh+100→ 29,612 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-03-11$42.76/sh−100→ 23,200 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-03-08$42.76/sh−1,700→ 23,300 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-08$140.05/sh−1,700→ 29,512 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-03-08$42.76/sh+1,700→ 31,212 total
Award
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2024-02-26+274,328→ 274,328 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-20$12.98/sh+15,000→ 44,512 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2024-02-20$12.98/sh−15,000→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2024-02-20$132.47/sh−15,000→ 29,512 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2024-02-08$26.77/sh−91,757→ 1,179,675 total
Award
Alkermes plc.$ALKS
Ordinary Shares
2024-02-08+218,551→ 1,271,432 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$20.03/sh+7,168→ 365,634 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$46.24/sh+4,599→ 234,599 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$53.50/sh+3,999→ 203,999 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$65.94/sh+5,899→ 300,899 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$31.93/sh+2,419→ 123,419 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$31.93/sh+7,644→ 389,844 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$69.83/sh+3,999→ 203,999 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$24.59/sh+5,980→ 305,024 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$19.34/sh+6,843→ 349,030 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$26.82/sh+5,697→ 290,570 total
Other
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-11-17$31.64/sh+5,999→ 305,999 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Restricted Stock Unit
2023-05-17+4,199→ 4,199 total
Award
Alkermes plc.$ALKS
Employee Stock Option (Right to Buy)
2023-02-23+284,873→ 284,873 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2023-02-21$27.77/sh−14,386→ 1,052,881 total
Exercise/Conversion
Alkermes plc.$ALKS
Restricted Stock Unit Award
2023-02-21−32,400→ 0 total
Exercise/Conversion
Alkermes plc.$ALKS
Ordinary Shares
2023-02-21+32,400→ 1,067,267 total
Award
Alkermes plc.$ALKS
Ordinary Shares
2023-02-20+119,713→ 1,088,012 total
Tax Payment
Alkermes plc.$ALKS
Ordinary Shares
2023-02-20$28.07/sh−53,145→ 1,034,867 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2023-01-03$12.71/sh−15,000→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-01-03$119.20/sh−15,000→ 29,512 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2023-01-03$12.71/sh+15,000→ 44,512 total
Award
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2022-05-18+9,724→ 9,724 total
Exercise/Conversion
NEUROCRINE BIOSCIENCES INC$NBIX
Non-Qualified Stock Option
2022-05-09$6.66/sh−7,500→ 0 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2022-05-09$76.29/sh−7,500→ 29,512 total
Sale
NEUROCRINE BIOSCIENCES INC$NBIX
Common Stock
2022-05-09$76.30/sh−7,500→ 29,512 total

Companies

Recent Filings

Address

88 SIDNEY STREET

CAMBRIDGE, MA, 02139

View on SEC.gov